How They Work: The Mechanism Difference
Semaglutide is a pure GLP-1 receptor agonist. It mimics the GLP-1 hormone your body naturally produces after eating, which reduces appetite, slows gastric emptying, and improves insulin sensitivity. Brands include Ozempic (diabetes indication) and Wegovy (weight management indication).
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates two incretin receptors instead of one. This dual mechanism is why clinical trials consistently show higher average weight loss with tirzepatide. Brands include Mounjaro (diabetes) and Zepbound (weight management).
The practical difference: semaglutide targets one hormonal pathway. Tirzepatide targets two. Both are administered as once-weekly subcutaneous injections.
Tirzepatide's dual-receptor mechanism is not just a marketing difference — it translates to measurably greater weight loss in head-to-head data.
Weight Loss Results: Head-to-Head Data
The clinical trial data is clear and consistent across multiple large-scale studies:
| Metric | Semaglutide (2.4mg) | Tirzepatide (15mg) |
|---|---|---|
| Average weight loss | 15-17% of body weight | 20-22.5% of body weight |
| Participants losing 5%+ | 84% | 91% |
| Participants losing 10%+ | 69% | 79% |
| Participants losing 20%+ | 32% | 57% |
| Key trial | STEP trials (2021-2023) | SURMOUNT trials (2022-2024) |
For a 220-pound man, that translates to roughly 33-37 pounds on semaglutide versus 44-50 pounds on tirzepatide at maximum dose. The gap widens at higher weight loss thresholds — 57% of tirzepatide patients lost 20%+ versus only 32% on semaglutide.
Important caveat: these are averages from clinical trials with specific populations. Individual results vary based on starting weight, diet, exercise, metabolic health, and adherence to the medication.
Side Effects Compared
Both medications share a similar side effect profile because they work on overlapping pathways. The most common effects are gastrointestinal:
| Side Effect | Semaglutide | Tirzepatide |
|---|---|---|
| Nausea | 44% | 31% |
| Diarrhea | 30% | 23% |
| Vomiting | 24% | 12% |
| Constipation | 24% | 13% |
| Injection site reaction | 3.2% | 3.4% |
Tirzepatide actually shows lower rates of nausea and vomiting in clinical trials despite producing greater weight loss. Both medications use a dose-titration protocol — starting low and increasing gradually over weeks — which significantly reduces GI side effects.
Most side effects resolve within the first 4-6 weeks as your body adjusts. Your provider manages this by controlling the titration schedule.
Side effects are dose-dependent. A slow titration schedule minimizes GI symptoms for both medications. If nausea persists, your provider can hold at a lower dose longer.
Cost and Insurance Coverage
Cash pricing without insurance varies significantly and changes frequently, but the general landscape in 2026:
Semaglutide (brand Wegovy): $800-1,300/month retail. Generic and compounded versions are emerging at lower price points. Heyday offers semaglutide starting at $299/month through compounding pharmacy partnerships.
Tirzepatide (brand Zepbound): $1,000-1,200/month retail. Fewer compounding options currently available. Insurance coverage is expanding but still inconsistent.
Insurance coverage depends entirely on your plan, your BMI, and whether the indication is weight management or diabetes. Many employer plans now cover GLP-1 medications for weight loss, but prior authorization is almost always required.
For men paying out of pocket, compounded semaglutide through a telehealth provider like Heyday is typically the most cost-effective option while maintaining pharmaceutical-grade quality and medical oversight.
Which Is Better for Men Specifically?
Both medications work well for men, but there are some considerations specific to male patients:
If your primary goal is maximum weight loss and you can access tirzepatide (via insurance or budget allows), the data favors tirzepatide. The 5-7% additional weight loss over semaglutide is clinically significant.
If you are combining GLP-1 with testosterone replacement therapy, either medication works synergistically. TRT preserves lean mass during rapid weight loss, while GLP-1 drives fat reduction. The combination produces body recomposition — losing fat while maintaining or building muscle — faster than either treatment alone.
If cost is a factor (and it usually is), semaglutide through a telehealth GLP-1 program offers the best value per pound of weight loss. Compounded semaglutide at $299/month that produces 15-17% weight loss is a better ROI than retail tirzepatide at $1,200/month for 20-22% loss.
If you have type 2 diabetes alongside obesity, tirzepatide shows superior A1C reduction (2.1-2.4% vs 1.6-1.8% for semaglutide). Your endocrinologist may prefer it for dual glycemic and weight management.
Semaglutide is the value play. Tirzepatide is the performance play. Both produce life-changing weight loss. The best medication is the one you can afford, access, and stick with consistently.
Combining GLP-1 with TRT
For men with both low testosterone and excess weight, the combination of GLP-1 medication with testosterone replacement therapy is one of the most effective body recomposition protocols available.
The vicious cycle: low testosterone promotes fat storage (especially visceral fat). Visceral fat contains aromatase enzymes that convert testosterone to estrogen, further lowering T levels. More fat equals lower T equals more fat.
GLP-1 breaks the fat side of the cycle. TRT breaks the hormonal side. Together, they create a virtuous cycle: less fat means less aromatase, means higher free testosterone, means more lean mass, means higher metabolic rate, means more fat loss.
At Heyday, providers can prescribe both TRT and GLP-1 under one coordinated protocol. This eliminates the fragmented care problem where your TRT provider does not know what your weight loss provider is prescribing, and vice versa.
How to Get Started
If you are considering GLP-1 medication for weight loss, the first step is determining whether you are clinically eligible. General criteria include a BMI over 30, or over 27 with weight-related conditions like hypertension, diabetes, or sleep apnea.
Heyday's process: take the 60-second eligibility quiz, order your at-home lab kit to establish baseline metabolic markers, then meet with a licensed provider who will recommend the best protocol based on your specific labs, goals, and budget.
Your provider will discuss whether semaglutide or tirzepatide (if available) is the right fit, and whether combining with TRT makes sense based on your testosterone levels.